Download presentation
Presentation is loading. Please wait.
Published byDaniela Garces Modified over 9 years ago
1
DR-TB pacientebis mier samkurnalo reJimebis Sesruleba “samSabaToba” 29.06.10 cira Caxaia, TamTa komaxiZe
2
axali da warsulSi namkurnalebi pacientebis mier samkurnalo reJimebis Sesrulebis Sefaseba ganyofilebebisa da Tveebis mixedviT preparatebis arasrulyofilad miRebis daxasiaTeba gamotovebuli dozebisa da dReebis mixedviT dozis arasrulad miRebis sixSiris gansazRvra im preparatebis gamovlena, romelTa arasruli doziT miReba xdeba upiratesad mizani
3
samkurnalo reJimebis arasrulyofilad Sesrulebis mizezebis gansazRvra stacionarul da ambulatoriul pirobebSi samkurnalo reJimebis Sesrulebis Sedareba asocirebuli kavSiris dadgena preparatebis arasrul miRebasa da DST profilis cvlilebas Soris asocirebuli kavSiris dadgena samkurnalo reJimis Sesrulebasa da mkurnalobis gamosavals Soris mizani
4
2010 wlis ianvarSi, TebervalSi, martsa da aprilSi gawerili DR-TB pacientebis monacemebi Segrovda da damuSavda tfdec-is I, III da V Terapiuli ganyofilebebidan (maisis monacemebi Tavad ganyofilebebma daamuSaves) monacemebi Segrovda pacientTa monacemebi Segrovda pacientTa mkurnalobis monitoringis formis safuZvelze; specialurad Seqmnili kiTxvaris daxmarebiT monacemebi damuSavda Epi-info -s programiT meTodologia
5
samkurnalo reJimis Sesruleba srulyofilad CaiTvala, Tu Tvis ganmavlobaSi arcerTi preparati arcerTxel ar iyo gamotovebuli Tvis ganmavlobaSi erTi dozis gamotovebac ki arasrulyofil samkurnalo reJimad CaiTvala arasrulyofili samkurnalo reJimi daiyo: dozebis mixedviT – 1, 2, 3 da yvela preparatis gamotoveba dReebis mixedviT – 1-2, 3-9, 10 da meti dRis gamotoveba kiTxvari
6
DR-T BN % PDR-TB 44,3% MDR-TB 80 87,0% XDR-TB 88,7% sul 92100,0%
7
MDR-TB SemTxvevebis ganawileba ganyofilebebis mixedviT
8
axali da warsulSi I da II rigis TB preparatebiT namkurnalebi pacientebis sixSire SemTxveva N % axali3335.9% warsulSi namkurnalebi5964.1% sul92100.0% warsulSi namkurnalebi N % I3762.7% II2237.3% sul59100.0%
9
axali da warsulSi namkurnalebi SemTxvevebis ganawileba ganyofilebebis mixedviT
10
axali da warsulSi namkurnalebi pacientebis mier samkurnalo reJimis Sesruleba (ianvari)
11
axali da warsulSi namkurnalebi pacientebis mier samkurnalo reJimis Sesruleba (Tebervali)
12
axali da warsulSi namkurnalebi pacientebis mier samkurnalo reJimis Sesruleba (marti)
13
axali da warsulSi namkurnalebi pacientebis mier samkurnalo reJimis Sesruleba (aprili)
14
samkurnalo reJimis Sesrulebis dinamika Tveebis mixedviT
15
samkurnalo reJimis Sesruleba Tveebis mixedviT samkurnalo reJimis Sesruleba N (%) ianvariTebervalimartiaprili srulad 15 (21.4%) 23 (36.5%) 20 (43.5%) 2 (11.1%) arasrulad55 (78.6%)40 (63.5%)26 (56.5%)16 (88.9%) sul70 (100%)63 (100%)46 (100%)18 (100%)
16
samkurnalo reJimis Sesruleba ganyofilebebis mixedviT (ianvari)
17
samkurnalo reJimis Sesruleba ganyofilebebis mixedviT (Tebervali)
18
samkurnalo reJimis Sesruleba ganyofilebebis mixedviT (marti)
19
samkurnalo reJimis Sesruleba ganyofilebebis mixedviT (aprili)
20
yvela preparatis gamotoveba
21
erTipreparatis gamotoveba
22
ori preparatis gamotoveba
23
sami preparatis gamotoveba
24
samze meti, magram arayvela preparatis gamotoveba
25
PAS- is gamotoveba Tveebis mixedviT
26
Pto- is gamotoveba Tveebis mixedviT
27
axal SemTxvevebTan SedarebiT warsulSi namkurnalebi pacientebi samkurnalo reJims gacilebiT ufro xSirad arRveven gacilebiT xSiria preparatebis arasrulyofilad miReba reJimebis arasrulad Sesrulebis SemTxvevebSi sWarbobs 1, 2, an 3 preparatis 1-2 da 3-9 dRis ganmavlobaSi gamotovebis sixSire Tveebis mixedviT samkurnalo reJimebis Sesruleba gansxvavebuli da arastabiluria rogorc mosalodneli iyo upiratesad xdeba PAS -is da Pto -is dozebis da dReebis mixedviT gamotoveba daskvna
28
preparatebis srulyofilad da arasrulyofilad miRebis sixSire ganyofilebebis mixedviT (maisi, 2010)
29
preparatebis xarjva (I Terapiuli gany.)
30
preparatebis xarjva (III Terapiuli gany.)
32
Cm -is gamotovebis mizezebis sixSire (I Terapia)
33
PAS -is gamotovebis mizezebis sixSire (III Terapia)
34
preparatebis gamotovebis mizezebis sixSire (V Terapia)
35
gmadlobT yuradRebisaTvis
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.